Estimated coefficient of variation values for sample size planning in bioequivalence studies.
OBJECTIVE
The aim of the present communication is to provide information regarding the intrasubject coefficent of variation obtained from 30 bioequivalence studies covering 16 drugs which can be used for estimation of sample size. Additionally, an attempt was also made to estimate the test power of each of the studies conducted.


METHODS
The intrasubject coefficient of variation was estimated from the residual mean square error obtained from analysis of variance of the parameters AUC0-infinity, Cmax and Cmax/AUC0-infinity after logarithmic transformation. The test power in the analyses of the above parameters was subsequently estimated using nomograms provided by Diletti et al. [1991].


CONCLUSIONS
Thirty products covering 16 drugs were studied in which 22 were immediate-release (including one dispersible tablet) and 8 were sustained-release formulations. The intrasubject coefficient of variation for the parameter AUC0-infinity was smaller than Cmax, and hence considerably more studies were able to attain a power of greater than 80% using 12 volunteers for the AUC0-infinity, compared to the Cmax. However, the variability in the Cmax could be reduced by using the parameter Cmax/ AUC0-infinity, and thus, provide a more realistic estimation of sample size, since the latter reflects only the rate of absorption and not both the rate and extent as in the case of Cmax [Endrenyi et al. 1991].
Yuen
K H
KH
School of Pharmaceutical Sciences, University of Science Malaysia, Penang, Malaysia.
Wong
J W
JW
Yap
S P
SP
Billa
N
N
D000042:Absorption; D019540:Area Under Curve; D004358:Drug Therapy / Q000706:statistics & numerical data*; D006801:Humans; D010599:Pharmacokinetics; D015203:Reproducibility of Results; D012107:Research Design; D018401:Sample Size; D013810:Therapeutic Equivalency